KRAS and non-small cell lung carcinoma: Studies from Guo et al. (142, 143) revealed that in Kras-driven, genetically engineered mouse models of non-small-cell lung cancer (NSCLC), deletion of Atg7 caused accumulation of mitochondria, suppression of tumor growth and the promotion of tumor cell death.